Michael Okunewitch Stock Analyst Profile - Maxim Group Research Coverage - Stocknear

Michael Okunewitch

Stock Analyst at Maxim Group

(2.75)
# 3089
Out of 5,478 analysts
29
Total ratings
Success rate
Average return
20 Stocks
Name Action PT Current % Upside Ratings Updated
ANEB Anebulo Pharmaceutic...
Downgrades: Hold
n/a
n/a n/a 3 Jul 23, 2025
HCWB HCW Biologics
Maintains: Buy
120 35
5.59 526.12% 2 May 29, 2025
CTOR Citius Oncology
Downgrades: Hold
n/a
n/a n/a 2 May 23, 2025
RADX Radiopharm Theranost...
Initiates Coverage On: Buy
12
6.46 85.76% 1 May 1, 2025
CMMB Chemomab Therapeutic...
Maintains: Strong Buy
16 28
3.03 824.09% 2 Feb 20, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
14
1.66 743.37% 1 Feb 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
5 3
1.33 125.56% 1 Jan 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
4
1.07 273.83% 1 Oct 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
12
0.54 2122.22% 1 Sep 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
15 6
0.79 659.49% 2 Aug 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
3 12
1.19 908.4% 2 Mar 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
2
n/a n/a 1 Dec 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
24
1.52 1478.95% 1 Oct 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
108 18
2.64 581.82% 3 Aug 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
2025
2.41 83924.9% 1 Apr 12, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
25
17.84 40.13% 1 Dec 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
6
1.54 289.61% 1 Sep 28, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
120
n/a n/a 1 Feb 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
25
4.63 439.96% 1 Nov 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
100
1.21 8164.46% 1 Nov 30, 2021